Entrada Therapeutics (TRDA) Reports Q1 Net Loss of $21.7M

Go back to Entrada Therapeutics (TRDA) Reports Q1 Net Loss of $21.7M
(NASDAQ: TRDA) Delayed: 7.04 +0.09 (1.29%)
Previous Close $6.95    52 Week High
Open $7.00    52 Week Low
Day High $7.27    P/E N/A 
Day Low $6.93    EPS
Volume 264,102